(Per) Johan Luthman is Vice President and Head of Neuroscience Clinical Development, Eisai Pharmaceuticals, where he is engaged in overseeing clinical development programs from preclinical development to phase 3 in the area of neuroscience, with current programs in Alzheimer’s disease & other dementing disorders, epilepsy, sleep disorders and obesity.
Before joining Eisai, Johan was VP and Franchise Integrator, leading translational medicine and biomarker activities in neuroscience as well as Senior Program Leader for Early Development Neuroscience & Ophthalmology at Merck Research Laboratories, based in PA, USA, overseeing projects from preclinical candidate to proof of concept in Phase 2. Prior to Merck, Johan led GeNeuro SA, Geneva, as CEO during its build-up phase to a standalone biotechnology company. Before then, Johan was SVP & Therapy Area Head of Neurology, Immunology & Inflammation Research and Head of PoC strategy in Neurology at MerckSerono, based in Geneva, CH. He joined Serono in 2005, as Head Neuroscience & Immunology Research. Johan began his pharmaceutical career in 1991 in Astra, Sodertalje, Sweden. In Astra/AstraZeneca he worked as project leader as well as director of research departments, before leading Translational Science in Neurology & Analgesia. During his years in the industry, Johan has been engaged in numerous Public-Private pre-competitive consortia efforts, including acting as chairman of the ADNI Industry group in 2012, and chair efforts within C-Path Institute.
Johan studied medicine and dentistry at the Karolinska Institute. In parallel with clinical practice, he obtained a Ph. D in neurobiology in 1989. He continued as a Research Fellow in Pharmacology & Psychiatry at the University of Colorado. Johan was subsequently appointed the associate professor in Neurobiology at Karolinska Institute and received an honorary professorship in pharmacology from the University of Chile. He obtained business training at SIMI, Copenhagen and Thunderbird and MIT/Sloan Management Institute.
Colin Miller Editor, Medical Imaging in Clinical Trials
Youngho Seo, Ph.D. Professor, Department of Radiology and Biomedical Imaging, UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Ira Smalberg, M.D. Diagnostic Radiology, TOWER IMAGING MEDICAL GROUP
Gary Ulaner, M.D., Ph.D. Associate Attending Radiologist, MEMORIAL SLOAN KETTERING CANCER CENTER